Nicole Mittmann
Chief Scientist and Vice-President of Scientific Evidence, Methodologies, and Resources, Canada’s Drug Agency
Nicole Mittmann is listed as Chief Scientist and Vice-President of Scientific Evidence, Methodologies, and Resources, Canada’s Drug Agency. Nicole spoke at ISPOR Europe 2026 in November 2026 (speaker, “Finding and Exploring HTA Methods: An Interactive Demonstration of the SUSTAIN Methods Observatory”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Nicole. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
In her Chief Scientist role, Dr. Mittmann is responsible for ensuring that CDA (a.ka. CADTH) actively learns, ensures rigour and quality, mobilizes evidence, and links science to strategy. In her role, Nicole leads CDA’s shared science groups, including the Science and Methods, Health Economics, Research Information Services, Publishing, Early Scientific Advice and Real-World Evidence teams. In her academic capacity, Dr. Mittmann holds an MSc and PhD in pharmacology from the University of Toronto. She holds a faculty position as an assistant professor at the University of Toronto in the Department of Pharmacology & Toxicology; and is cross-appointed to the Institute for Health Policy, Management and Evaluation. She is also an associate scientist at Sunnybrook Health Sciences Centre in Toronto, Canada. Dr. Mittmann has conducted and collaborated on notable research in the areas of economic evaluations, outcomes research, and drug/patient safety. Research methodologies include the ex
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Finding and Exploring HTA Methods: An Interactive Demonstration of the SUSTAIN Methods Observatory Speaker · 10 November 2026
Spoke alongside
People who have shared a session with Nicole at events on B2DB.
- Wim Goettsch Director EUnetHTA JA3 Directorate · Zorginstituut Nederland 1 shared session
- Saif Elayan Postdoctoral Researcher · Utrecht University 1 shared session
Others from Canada’s Drug Agency
- Zaina Albalawi Member, Formulary Management Expert Committee (FMEC) 2 sessions
- Sudha Kutty Executive Vice President, Evidence Products and Services 1 session